CIK 0001710072 · Large accelerated filer
Edgewise Therapeutics, Inc.
Sign in to watch- Ticker
- EWTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821725586
- Phone
- 720-262-7002
- Business address
- 1715 38TH ST, BOULDER, CO, 80301
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $201,787
- in 1 filing
Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-12 | Derakhshan Behrad Chief Business Officer | Grant or award · Restricted Stock Units | +23,125 | 23,125 | ||
| 2024-08-12 | KOCH KEVIN President and CEO | Grant or award · Stock Option (Right to Buy) | +431,250 | 431,250 | ||
| 2024-08-12 | KOCH KEVIN President and CEO | Grant or award · Restricted Stock Units | +71,875 | 71,875 | ||
| 2024-08-12 | Donovan Joanne M. CMO | Grant or award · Stock Option (Right to Buy) | +138,750 | 138,750 | ||
| 2024-08-12 | Donovan Joanne M. CMO | Grant or award · Restricted Stock Units | +23,125 | 23,125 | ||
| 2024-08-12 | Carruthers R Michael Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +138,750 | 138,750 | ||
| 2024-08-12 | Carruthers R Michael Chief Financial Officer | Grant or award · Restricted Stock Units | +23,125 | 23,125 | ||
| 2024-06-10 | Thompson Peter A. Director | Grant or award · Stock Options (Right to buy) | +20,594 | 20,594 | ||
| 2024-06-10 | Fox Jonathan C Director | Grant or award · Stock Option (Right to Buy) | +20,594 | 20,594 | ||
| 2024-06-10 | Morris Arlene Director | Grant or award · Stock Option (Right to Buy) | +20,594 | 20,594 | ||
| 2024-06-10 | Brege Laura Director | Grant or award · Stock Option (Right to Buy) | +20,594 | 20,594 | ||
| 2024-06-10 | Edris Badreddin Director | Grant or award · Stock Option (Right to Buy) | +20,594 | 20,594 | ||
| 2024-06-10 | ROOT JONATHAN D Director | Grant or award · Stock Option (Right to Buy) | +20,594 | 20,594 | ||
| 2024-05-06 | Morris Arlene Director | Grant or award · Stock Options (Right to buy) | +34,311 | 34,311 | ||
| 2024-05-02 | MOORE JOHN R General Counsel | Sale | −1,956 | $18.91 | $37K | 3,252 |
| 2024-05-02 | Carruthers R Michael Chief Financial Officer | Sale | −2,157 | $18.91 | $41K | 35,230 |
| 2024-05-02 | Derakhshan Behrad Chief Business Officer | Sale | −1,718 | $18.91 | $32K | 13,422 |
| 2024-05-02 | Russell Alan J Chief Scientific Officer | Sale | −1,576 | $18.91 | $30K | 7,238 |
| 2024-05-02 | Donovan Joanne M. CMO | Sale | −3,682 | $18.91 | $70K | 19,897 |
| 2024-05-02 | KOCH KEVIN President and CEO | Sale | −3,152 | $18.91 | $60K | 14,478 |
Page 13 of 26 · 509 trades